|
1
|
Torre LA, Siegel RL and Jemal A: Lung
cancer statistics. Adv Exp Med Biol. 893:1–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grønberg BH, Lund-Iversen M, Strøm EH,
Brustugun OT and Scott H: Associations between TS, TTF-1, FR-α,
FPGS, and overall survival in patients with advanced non-small-cell
lung cancer receiving pemetrexed plus carboplatin or gemcitabine
plus carboplatin as first-line chemotherapy. J Thorac Oncol.
8:1255–1264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heist RS and Engelman JA: SnapShot:
Non-small cell lung cancer. Cancer Cell. 21:448.e22012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Scagliotti GV, Parikh P, von Pawel J,
Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U,
Digumarti R, Zukin M, et al: Phase III study comparing cisplatin
plus gemcitabine with cisplatin plus pemetrexed in
chemotherapy-naive patients with advanced-stage non-small-cell lung
cancer. J Clin Oncol. 26:3543–3551. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li L, Song L, Liu X, Yang X, Li X, He T,
Wang N, Yang S, Yu C, Yin T, et al: Artificial virus delivers
CRISPR-Cas9 system for genome editing of cells in mice. ACS Nano.
11:95–111. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mohammad IS, He W and Yin L: Understanding
of human ATP binding cassette superfamily and novel multidrug
resistance modulators to overcome MDR. Biomed Pharmacother.
100:335–348. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song L, Liang X, Yang S, Wang N, He T,
Wang Y, Zhang L, Wu Q and Gong C: Novel
polyethyleneimine-R8-heparin nanogel for high-efficiency gene
delivery in vitro and in vivo. Drug Deliv. 25:122–131. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patrini D, Panagiotopoulos N, Bedetti B,
Mitsos S, Crisci R, Solli P, Bertolaccini L and Scarci M: Surgical
approach in oligometastatic non-small cell lung cancer. Ann Transl
Med. 6:932018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheng H and Perez-Soler R: Leptomeningeal
metastases in non-small-cell lung cancer. Lancet Oncol. 19:e43–e55.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang JL, Zheng L, Hu YW and Wang Q:
Characteristics of long non-coding RNA and its relation to
hepatocellular carcinoma. Carcinogenesis. 35:507–514. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen QN, Wei CC, Wang ZX and Sun M: Long
non-coding RNAs in anti-cancer drug resistance. Oncotarget.
8:1925–1936. 2017.PubMed/NCBI
|
|
15
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tripathi V, Shen Z, Chakraborty A, Giri S,
Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A and
Prasanth KV: Long noncoding RNA MALAT1 controls cell cycle
progression by regulating the expression of oncogenic transcription
factor B-MYB. PLoS Genet. 9:e10033682013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ruan W, Wang P, Feng S, Xue Y and Li Y:
Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12)
promotes cell proliferation and migration by upregulating
angiomotin gene expression in human osteosarcoma cells. Tumour
Biol. 37:4065–4073. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tuo YL, Li XM and Luo J: Long noncoding
RNA UCA1 modulates breast cancer cell growth and apoptosis through
decreasing tumor suppressive miR-143. Eur Rev Med Pharmacol Sci.
19:3403–3411. 2015.PubMed/NCBI
|
|
20
|
Cao C, Zhang T, Zhang D, Xie L, Zou X, Lei
L, Wu D and Liu L: The long non-coding RNA SNHG6-003, functions as
a competing endogenous RNA to promote the progression of
hepatocellular carcinoma. Oncogene. 36:1112–1122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou X, Ji G, Ke X, Gu H, Jin W and Zhang
G: MiR-141 inhibits gastric cancer PROLIFERATION BY interacting
with long noncoding RNA MEG3 and down-regulating E2F3 expression.
Dig Dis Sci. 60:3271–3282. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li H, Li J, Jia S, Wu M, An J, Zheng Q,
Zhang W and Lu D: miR675 upregulates long noncoding RNA H19 through
activating EGR1 in human liver cancer. Oncotarget. 6:31958–31984.
2015.PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Iorio MV and Croce CM: microRNA
involvement in human cancer. Carcinogenesis. 33:1126–1133. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lan T, Ma W, Hong Z, Wu L, Chen X and Yuan
Y: Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12)
promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in
hepatocellular carcinoma. J Exp Clin Cancer Res. 36:112017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang P, Chen D, Ma H and Li Y: LncRNA
SNHG12 contributes to multidrug resistance through activating the
MAPK/Slug pathway by sponging miR-181a in non-small cell lung
cancer. Oncotarget. 8:84086–84101. 2017.PubMed/NCBI
|
|
28
|
Zhang T, Li J, Dong Y, Zhai D, Lai L, Dai
F, Deng H, Chen Y, Liu M and Yi Z: Cucurbitacin E inhibits breast
tumor metastasis by suppressing cell migration and invasion. Breast
Cancer Res Treat. 135:445–458. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tan X, Banerjee P, Guo HF, Ireland S,
Pankova D, Ahn YH, Nikolaidis IM, Liu X, Zhao Y, Xue Y, et al:
Epithelial-to-mesenchymal transition drives a pro-metastatic Golgi
compaction process through scaffolding protein PAQR11. J Clin
Invest. 127:117–131. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Krebs AM, Mitschke J, Lasierra Losada M,
Schmalhofer O, Boerries M, Busch H, Boettcher M, Mougiakakos D,
Reichardt W, Bronsert P, et al: The EMT-activator Zeb1 is a key
factor for cell plasticity and promotes metastasis in pancreatic
cancer. Nat Cell Biol. 19:518–529. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kraljevic Pavelic S, Sedic M, Bosnjak H,
Spaventi S and Pavelic K: Metastasis: New perspectives on an old
problem. Mol Cancer. 10:222011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jin Y, Li F, Zheng C, Wang Y, Fang Z, Guo
C, Wang X, Liu H, Deng L, Li C, et al: NEDD9 promotes lung cancer
metastasis through epithelial-mesenchymal transition. Int J Cancer.
134:2294–2304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mallini P, Lennard T, Kirby J and Meeson
A: Epithelial-to-mesenchymal transition: What is the impact on
breast cancer stem cells and drug resistance. Cancer Treat Rev.
40:341–348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nagaraju GP, Long TE, Park W, Landry JC,
Taliaferro-Smith L, Farris AB, Diaz R and El-Rayes BF: Heat shock
protein 90 promotes epithelial to mesenchymal transition, invasion,
and migration in colorectal cancer. Mol Carcinog. 54:1147–1158.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT-inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014. View
Article : Google Scholar : PubMed/NCBI
|
